Centiva Capital, LP Dexcom Inc Transaction History
Centiva Capital, LP
- $4.65 Billion
- Q4 2024
A detailed history of Centiva Capital, LP transactions in Dexcom Inc stock. As of the latest transaction made, Centiva Capital, LP holds 9,477 shares of DXCM stock, worth $837,482. This represents 0.02% of its overall portfolio holdings.
Number of Shares
9,477
Previous 7,900
19.96%
Holding current value
$837,482
Previous $529,000
39.32%
% of portfolio
0.02%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding DXCM
# of Institutions
1,085Shares Held
352MCall Options Held
8.45MPut Options Held
5.75M-
Vanguard Group Inc Valley Forge, PA46.5MShares$4.11 Billion0.06% of portfolio
-
Black Rock Inc. New York, NY34.5MShares$3.05 Billion0.09% of portfolio
-
State Street Corp Boston, MA16.7MShares$1.47 Billion0.05% of portfolio
-
Baillie Gifford & CO14.6MShares$1.29 Billion0.9% of portfolio
-
Capital Research Global Investors Los Angeles, CA14.4MShares$1.27 Billion0.24% of portfolio
About DEXCOM INC
- Ticker DXCM
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 386,257,984
- Market Cap $34.1B
- Description
- DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...